- Home
- APVO vs SGN Comparison
APVO vs SGN Comparison
Compare APVO & SGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- SGN
- Stock Information
- Founded
- APVO 2016
- SGN 2019
- Country
- APVO United States
- SGN United States
- Employees
- APVO N/A
- SGN N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- SGN
- Sector
- APVO Health Care
- SGN
- Exchange
- APVO Nasdaq
- SGN Nasdaq
- Market Cap
- APVO 4.1M
- SGN 3.8M
- IPO Year
- APVO N/A
- SGN 2023
- Fundamental
- Price
- APVO $3.23
- SGN $1.07
- Analyst Decision
- APVO Strong Buy
- SGN
- Analyst Count
- APVO 1
- SGN 0
- Target Price
- APVO $5,920.00
- SGN N/A
- AVG Volume (30 Days)
- APVO 6.7M
- SGN 1.0M
- Earning Date
- APVO 08-07-2025
- SGN 08-18-2025
- Dividend Yield
- APVO N/A
- SGN N/A
- EPS Growth
- APVO N/A
- SGN N/A
- EPS
- APVO N/A
- SGN N/A
- Revenue
- APVO N/A
- SGN $529,282.00
- Revenue This Year
- APVO N/A
- SGN N/A
- Revenue Next Year
- APVO N/A
- SGN N/A
- P/E Ratio
- APVO N/A
- SGN N/A
- Revenue Growth
- APVO N/A
- SGN 8.42
- 52 Week Low
- APVO $2.81
- SGN $0.44
- 52 Week High
- APVO $485.37
- SGN $36.70
- Technical
- Relative Strength Index (RSI)
- APVO 34.28
- SGN 50.21
- Support Level
- APVO $2.81
- SGN $0.98
- Resistance Level
- APVO $13.11
- SGN $1.35
- Average True Range (ATR)
- APVO 1.10
- SGN 0.16
- MACD
- APVO 0.30
- SGN -0.02
- Stochastic Oscillator
- APVO 4.08
- SGN 35.23
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.